Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
"Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.
| Descriptor ID |
D056648
|
| MeSH Number(s) |
C14.907.940.897.249 C20.111.193
|
| Concept/Terms |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis
- ANCA-Associated Vasculitis
- ANCA Associated Vasculitis
- Vasculitis, ANCA-Associated
- Pauci-Immune Vasculitis
- Pauci Immune Vasculitis
- Pauci-Immune Vasculitides
- Vasculitides, Pauci-Immune
- Vasculitis, Pauci-Immune
- ANCA-Associated Vasculitides
- ANCA Associated Vasculitides
- ANCA-Associated Vasculitide
- Vasculitide, ANCA-Associated
- Vasculitides, ANCA-Associated
|
Below are MeSH descriptors whose meaning is more general than "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis".
Below are MeSH descriptors whose meaning is more specific than "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis".
This graph shows the total number of publications written about "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" by people in this website by year, and whether "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 17 | 2 | 19 |
| 2018 | 21 | 5 | 26 |
| 2019 | 8 | 1 | 9 |
| 2020 | 3 | 0 | 3 |
| 2021 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" by people in Profiles.
-
Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA coronavirus disease-19 vaccine. QJM. 2021 12 20; 114(10):737-738.
-
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab. Nephrol Dial Transplant. 2021 08 27; 36(9):1758-1760.
-
Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey. Rheumatol Int. 2021 Nov; 41(11):1941-1947.
-
A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality? Kidney Int. 2021 10; 100(4):937-938.
-
Pediatric P-ANCA vasculitis following COVID-19. Pediatr Pulmonol. 2021 10; 56(10):3422-3424.
-
New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report. BMC Pediatr. 2021 08 05; 21(1):333.
-
Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort Study. Arthritis Rheumatol. 2021 09; 73(9):1713-1719.
-
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021 10; 78(4):611-613.
-
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis. Rheumatology (Oxford). 2021 07 01; 60(7):3476-3477.
-
Mechanisms of thrombosis in ANCA-associated vasculitis. Clin Rheumatol. 2021 Dec; 40(12):4807-4815.